id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1992-N-0056-0018,FDA,FDA-1992-N-0056,Notice re Prescription Drug Marketing Act Pedigree Requirements under 21 CFR Part 203 Compliance Policy Guide and Guidance for Industry: Prescription Drug Marketing Act Pedigree Requirements Questions and Answers; Notice of Availability,Notice,General Notice,2006-11-15T05:00:00Z,2006,11,2006-11-14T05:00:00Z,,2016-11-08T14:36:00Z,,0,0,090000648052c00a
FDA-1992-N-0056-0020,FDA,FDA-1992-N-0056,Guidance for Industry; Prescription Drug Marketing Act (PDMA) Requirements; Questions and Answers,Other,Guidance,2006-11-13T05:00:00Z,2006,11,2006-11-13T05:00:00Z,,2024-11-12T23:20:54Z,,1,0,09000064846c03dd
FDA-1992-N-0056-0017,FDA,FDA-1992-N-0056,Notice of Final Rule re Distribution of Blood Derivatives by Registered Blood Establishments Qualify as Health Care Entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; Delay of Applicability Date,Notice,Notice of Final Rule,2006-11-13T05:00:00Z,2006,11,2006-11-09T05:00:00Z,,2016-11-08T14:39:45Z,,0,0,090000648052c009
FDA-1992-N-0056-0016,FDA,FDA-1992-N-0056,"Petition Denial from FDA/CDER to Kleinfeld, Kaplan and Becker, LLP",Other,Petition(s),2006-08-10T04:00:00Z,2006,8,,,2017-01-18T18:42:50Z,,0,0,090000648052bfe6
FDA-1992-N-0056-0015,FDA,FDA-1992-N-0056,Notice of Final Rule re Prescription Drug Marketing Act Pedigree Requirements; Effective Date and Compliance Policy Guide; Request for Comment,Notice,Notice of Final Rule,2006-06-14T04:00:00Z,2006,6,,,2016-11-23T18:14:25Z,,0,0,090000648052bfe4
FDA-1992-N-0056-0014,FDA,FDA-1992-N-0056,"Acknowledgement Letter from HFA-305 to Kleinfeld, Kaplan, & Becker, LLP",Other,Acknowledgement Letter/Receipt,2006-01-30T05:00:00Z,2006,1,,,2016-11-08T21:16:20Z,,0,0,090000648052bfe3